Video series: Transforming SCLC care

Accredited video series: Extensive-stage small-cell lung cancer management (EBAC accredited; up to 40 minutes of CME)

Gain insights into the management of extensive-stage small-cell lung cancer (ES-SCLC) with Jacob Sands (Harvard Medical School, Boston, Massachusetts, USA), Eric Singhi (The University of Texas MD Anderson Cancer Center, Houston, USA), and Stephanie McDonald (Dana-Farber Cancer Institute, Boston, Massachusetts, USA). In these accredited videos, they discuss later-line management strategies, including emerging evidence and how clinical data can be applied in practice, as well as how best to support patients during the management of ES-SCLC. Earn up to 40 minutes of CME upon successful completion.

These videos are part of an accredited series for oncologists, including thoracic oncologists, involved in the care of people with ES-SCLC.

A total of 1 CME credit is available across all three episodes, with each episode worth up to 20 minutes of CME. To claim credit for an episode, complete the associated knowledge quiz and evaluation form after viewing the video. To claim credit for more than one video, complete the full assessment.

Available now

• Episode 1 – Later-line management of ES-SCLC: Applying evidence to practice
• Episode 2 – Supporting patients every step of the way

Coming soon

• Episode 3 – What are the current treatment options for people with ES-SCLC?

Available in November

How to claim your CME credit

1. Watch the video(s)
2. At the end of the video(s), make a note of the CME code(s)
3. Complete the knowledge quiz and evaluation form to claim your CME certificate

Important note: If you are not logged into your Medthority account, please complete the full session without exiting your browser. If you exit before finishing, you’ll need to restart from the beginning. We recommend logging in to preserve your progress if you need to pause. Not a member yet? You can set up your free account in just a few minutes.

Meet the experts

Jacob Sands, MD

Jacob Sands is Associate Chief of the Lowe Center for Thoracic Oncology, Boston, Massachusetts, USA, and Assistant Professor of Medicine at Harvard Medical School. He leads the small-cell lung cancer clinical and research program and has authored numerous publications in non–small-cell lung cancer (NSCLC) and SCLC. Sands serves on the National Comprehensive Cancer Network (NCCN) Small Cell Lung Cancer and Lung Screening Guidelines Committees and is co-founder and President of the Rescue Lung Society, a nonprofit dedicated to advancing lung cancer screening and early detection.

Disclosures: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Fosun, Genentech, Gilead, GSK, Jazz Pharmaceuticals, Lilly, Merck, Novartis, Pfizer, and Sanofi.

Eric Singhi, MD

Eric Singhi is Assistant Professor and Thoracic Medical Oncologist at The University of Texas MD Anderson Cancer Center, Houston, USA. He serves as medical oncology lead for the Young-Onset Lung Cancer Program, Director of Thoracic Research for the MD Anderson Cancer Network, and is a member of the American Society of Clinical Oncology (ASCO) NSCLC Guidelines Committee and International Association for the Study of Lung Cancer (IASLC) Communications Committee.

Disclosures: AstraZeneca, Novocure, Amgen, Janssen, Regeneron, Bristol Myers Squibb, Bayer, Lilly, Boehringer Ingelheim, Caris Life Sciences, AbbVie, GSK, Rexanna's Foundation for Fighting Lung Cancer, Roche, Sandoz, Summit Therapeutics, Nuvation Bio, Nuvalent, and EMD Serono.

Stephanie McDonald, MSN, FNP-BC, AOCNP

Stephanie McDonald is a Nurse Practitioner in the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, Boston, USA, specializing in the care of patients with SCLC and NSCLC. An internationally invited speaker and educator, she has expertise in novel lung cancer therapies, including T-cell engagers, antibody–drug conjugates, and immunotherapy, and has presented widely on supportive care, treatment-related toxicity management, and innovations in thoracic oncology. She is currently completing her Doctor of Nursing Practice at Boston College.

Disclosures: Amgen and AstraZeneca.